Prognosis After Discontinued Treatment due to Immune‐Related Adverse Events in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
In this study, irAEs were associated with a good prognosis. Furthermore, it was revealed that many of the cases in which treatment was permanently discontinued due to irAEs continued a durable response even after treatment ended.
Authors
- Ken Saijo (ORCID: https://orcid.org/0000-0003-0179-3789)
- Masashi Kuroki (ORCID: https://orcid.org/0000-0002-3199-009X)
- Yuki Asahi
- Takenori Ogawa (ORCID: https://orcid.org/0000-0003-1556-7328)
- Hirofumi Shibata (ORCID: https://orcid.org/0000-0002-7104-9456)
- Rina Kato
- Ryota Iinuma
- Masahiko Matsubara (ORCID: https://orcid.org/0000-0002-3608-6905)
- Ryo Kawaura (ORCID: https://orcid.org/0000-0002-8993-1834)
- Hiromasa Ishihara
- Hiroshi Okuda (ORCID: https://orcid.org/0000-0001-8374-3798)
- Tatsuhiko Yamada
- Saki Akita
Institutions
- Tohoku University (JP)
- Gifu University Hospital (JP)
- Gifu University (JP)
Publication Details
- Journal
- Head & Neck
- Published
- 2025-09-12
- DOI
- https://doi.org/10.1002/hed.70043
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00